EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction

Georgia P Wong iD, Sunhild Hartmann, David G Simmons, Sarah Ellis, Olivia Nonn, Ping Cannon, Tuong-Vi Nguyen, Anna Nguyen, Lucy A Bartho, Stephen Tong, Natalie J Hannan, Tu'uhevaha J Kaitu'u-Lino

Stem Cell Reviews and Reports · 2024

DOI: 10.1007/s12015-024-10764-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von Georgia P Wong und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Obstetrics, Gynaecology and Newborn Health, Mercy Hospital for Women, University of Melbourne, 163 Studley Road, Heidelberg, Victor…. Hauptthemen laut MEDLINE: Trophoblasts, Pre-Eclampsia, Fetal Growth Retardation, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, University of Melbourne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated progenitor cell populations may contribute to poor placental development and placental insufficiency pathogenesis. Side-population cells possess progenitor properties. Recent human trophoblast side-population isolation identified enrichment of 8 specific genes ( CXCL8, ELL2, GATA6, HK2, HLA-DPB1, INTS6, SERPINE3 and UPP1 ) (Gamage et al. 2020, Stem Cell Rev Rep ). We characterised these trophoblast side-population markers in human placenta and in placental insufficiency disorders: preeclampsia and fetal growth restriction (FGR). Trophoblast side-population markers localised to mononuclear trophoblasts lining the placental villous basement membrane in preterm control, preeclamptic and FGR placental sections ( n = 3, panel of 3 markers/serial section). Analysis of single-cell transcriptomics of an organoid human trophoblast stem cell (hTSC) to extravillous trophoblast (EVT) differentiation model (Shannon et al. 2022, Development ) identified that all side-population genes were enriched in mononuclear trophoblast and trophoblasts committed to differentiation under hTSC culture conditions. In vitro validation via 96 h time course hTSC differentiation to EVTs or syncytiotrophoblasts ( n = 5) demonstrated ELL2 and HK2 increased with differentiation ( p < 0.0024, p < 0.0039 respectively). CXCL8 and HLA-DPB1 were downregulated ( p < 0.030, p < 0.011 respectively). GATA6 and INTS6 increased with EVT differentiation only, and UPP1 reduced with syncytialisation. SERPINE3 was undetectable. Trophoblast side-population marker mRNA was measured in human placentas (< 34-weeks’ gestation; n = 78 preeclampsia, n = 30 FGR, and n = 18 gestation-matched controls). ELL2, HK2 and CXCL8 were elevated in preeclamptic ( p = 0.0006, p < 0.0001, p = 0.0335 respectively) and FGR placentas ( p = 0.0065, p < 0.0001, p = 0.0001 respectively) versus controls. Placental GATA6 was reduced in pregnancies with preeclampsia and FGR ( p = 0.0014, p = 0.0146 respectively). Placental INTS6 was reduced with FGR only ( p < 0.0001). This study identified the localisation of a unique trophoblast subset enriched for side-population markers. Aberrant expression of some side-population markers may indicate disruptions to unique trophoblast subtypes in placental insufficiency. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrophoblastsPre-EclampsiaFetal Growth RetardationBiomarkersHumansFemalePregnancyPlacentaCell DifferentiationAdult

Stichwörter der Autor:innen

Fetal growth restrictionPlacentaPreeclampsiaPregnancyTrophoblast

Substanzen

Biomarkers

Autor:innen und Institutionen

  • The Department of Obstetrics, Gynaecology and Newborn Health, Mercy Hospital for Women, University of Melbourne, 163 Studley Road, Heidelberg, Victoria, 3084, Australia. gpwong@student.unimelb.edu.au.
  • Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia. gpwong@student.unimelb.edu.au.
  • The Department of Obstetrics, Gynaecology and Newborn Health, Mercy Hospital for Women, University of Melbourne, 163 Studley Road, Heidelberg, Victoria, 3084, Australia.
  • Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
  • Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany.
  • Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Georgia P Wong

Förderung

  • Australian Research Council
  • National Health and Medical Research Council
  • University of Melbourne

Zitieren

APA

Wong, G. P., Hartmann, S., Simmons, D. G., Ellis, S., Nonn, O., Cannon, P., Nguyen, T. V., Nguyen, A., Bartho, L. A., Tong, S., Hannan, N. J., & Kaitu'u-Lino, T. J. (2024). Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10764-w

Vancouver

Wong GP, Hartmann S, Simmons DG, Ellis S, Nonn O, Cannon P, et al. Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10764-w

BibTeX
@article{Wong2024,
  author = {Wong, Georgia P and Hartmann, Sunhild and Simmons, David G and Ellis, Sarah and Nonn, Olivia and Cannon, Ping and Nguyen, Tuong-Vi and Nguyen, Anna and Bartho, Lucy A and Tong, Stephen and Hannan, Natalie J and Kaitu'u-Lino, Tu'uhevaha J},
  title = {Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction},
  journal = {Stem Cell Reviews and Reports},
  year = {2024},
  doi = {10.1007/s12015-024-10764-w}
}
Kostenlos starten →